Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients

The current antimicrobial market and old (pre-2000) in vitro antimicrobial susceptibility test interpretative criteria (STIC) are not working properly. Malfunctioning susceptibility breakpoints and antimicrobial markets have serious implications for both patients (ie, from a safety and efficacy pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, Paul G, Bhavnani, Sujata M, Andes, David R, Bradley, John S, Flamm, Robert K, Pogue, Jason M, Jones, Ronald N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336562/
https://www.ncbi.nlm.nih.gov/pubmed/32667364
http://dx.doi.org/10.1093/ofid/ofaa084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336562/
https://www.ncbi.nlm.nih.gov/pubmed/32667364
http://dx.doi.org/10.1093/ofid/ofaa084

Ejemplares similares